Mesothelioma Biomarkers

Volume: 30, Issue: 4, Pages: 395 - 423
Published: Nov 1, 2020
Abstract
Malignant pleural mesothelioma (MPM) is an asbestos-related neoplasm that can only be treated successfully when correctly diagnosed and treated early. The asbestos-exposed population is a high-risk group that could benefit from sensitive and specific blood- or tissue-based biomarkers. We review recent work with biomarker development in MPM and literature of the last 20 years on the most promising blood- and tissue-based biomarkers. Proteomic,...
Paper Details
Title
Mesothelioma Biomarkers
Published Date
Nov 1, 2020
Volume
30
Issue
4
Pages
395 - 423
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.